226 related articles for article (PubMed ID: 33986191)
1. Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.
Shuhaibar LC; Kaci N; Egbert JR; Horville T; Loisay L; Vigone G; Uliasz TF; Dambroise E; Swingle MR; Honkanen RE; Biosse Duplan M; Jaffe LA; Legeai-Mallet L
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986191
[TBL] [Abstract][Full Text] [Related]
2. Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism.
Wagner BM; Robinson JW; Lin YW; Lee YC; Kaci N; Legeai-Mallet L; Potter LR
JCI Insight; 2021 May; 6(9):. PubMed ID: 33784257
[TBL] [Abstract][Full Text] [Related]
3. Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor.
Shuhaibar LC; Robinson JW; Vigone G; Shuhaibar NP; Egbert JR; Baena V; Uliasz TF; Kaback D; Yee SP; Feil R; Fisher MC; Dealy CN; Potter LR; Jaffe LA
Elife; 2017 Dec; 6():. PubMed ID: 29199951
[TBL] [Abstract][Full Text] [Related]
4. 8-Nitro-cGMP promotes bone growth through expansion of growth plate cartilage.
Hoshino M; Kaneko K; Miyamoto Y; Yoshimura K; Suzuki D; Akaike T; Sawa T; Ida T; Fujii S; Ihara H; Tanaka J; Tsukuura R; Chikazu D; Mishima K; Baba K; Kamijo R
Free Radic Biol Med; 2017 Sep; 110():63-71. PubMed ID: 28559051
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Lorget F; Kaci N; Peng J; Benoist-Lasselin C; Mugniery E; Oppeneer T; Wendt DJ; Bell SM; Bullens S; Bunting S; Tsuruda LS; O'Neill CA; Di Rocco F; Munnich A; Legeai-Mallet L
Am J Hum Genet; 2012 Dec; 91(6):1108-14. PubMed ID: 23200862
[TBL] [Abstract][Full Text] [Related]
6. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Ozasa A; Komatsu Y; Yasoda A; Miura M; Sakuma Y; Nakatsuru Y; Arai H; Itoh N; Nakao K
Bone; 2005 Jun; 36(6):1056-64. PubMed ID: 15869918
[TBL] [Abstract][Full Text] [Related]
7. C-Type Natriuretic Peptide Analog as Therapy for Achondroplasia.
Legeai-Mallet L
Endocr Dev; 2016; 30():98-105. PubMed ID: 26684019
[TBL] [Abstract][Full Text] [Related]
8. Dephosphorylation is the mechanism of fibroblast growth factor inhibition of guanylyl cyclase-B.
Robinson JW; Egbert JR; Davydova J; Schmidt H; Jaffe LA; Potter LR
Cell Signal; 2017 Dec; 40():222-229. PubMed ID: 28964968
[TBL] [Abstract][Full Text] [Related]
9. Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.
Martin L; Kaci N; Estibals V; Goudin N; Garfa-Traore M; Benoist-Lasselin C; Dambroise E; Legeai-Mallet L
Hum Mol Genet; 2018 Jan; 27(1):1-13. PubMed ID: 29040558
[TBL] [Abstract][Full Text] [Related]
10. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Jonquoy A; Mugniery E; Benoist-Lasselin C; Kaci N; Le Corre L; Barbault F; Girard AL; Le Merrer Y; Busca P; Schibler L; Munnich A; Legeai-Mallet L
Hum Mol Genet; 2012 Feb; 21(4):841-51. PubMed ID: 22072392
[TBL] [Abstract][Full Text] [Related]
11. A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type.
Geister KA; Brinkmeier ML; Hsieh M; Faust SM; Karolyi IJ; Perosky JE; Kozloff KM; Conti M; Camper SA
Hum Mol Genet; 2013 Jan; 22(2):345-57. PubMed ID: 23065701
[TBL] [Abstract][Full Text] [Related]
12. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia.
Matsushita M; Kitoh H; Ohkawara B; Mishima K; Kaneko H; Ito M; Masuda A; Ishiguro N; Ohno K
PLoS One; 2013; 8(12):e81569. PubMed ID: 24324705
[TBL] [Abstract][Full Text] [Related]
13. FGFR3 induces degradation of BMP type I receptor to regulate skeletal development.
Qi H; Jin M; Duan Y; Du X; Zhang Y; Ren F; Wang Y; Tian Q; Wang X; Wang Q; Zhu Y; Xie Y; Liu C; Cao X; Mishina Y; Chen D; Deng CX; Chang Z; Chen L
Biochim Biophys Acta; 2014 Jul; 1843(7):1237-47. PubMed ID: 24657641
[TBL] [Abstract][Full Text] [Related]
14. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
Hannema SE; van Duyvenvoorde HA; Premsler T; Yang RB; Mueller TD; Gassner B; Oberwinkler H; Roelfsema F; Santen GW; Prickett T; Kant SG; Verkerk AJ; Uitterlinden AG; Espiner E; Ruivenkamp CA; Oostdijk W; Pereira AM; Losekoot M; Kuhn M; Wit JM
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1988-98. PubMed ID: 24057292
[TBL] [Abstract][Full Text] [Related]
15. C-type natriuretic peptide facilitates autonomic Ca
Miyazaki Y; Ichimura A; Kitayama R; Okamoto N; Yasue T; Liu F; Kawabe T; Nagatomo H; Ueda Y; Yamauchi I; Hakata T; Nakao K; Kakizawa S; Nishi M; Mori Y; Akiyama H; Nakao K; Takeshima H
Elife; 2022 Mar; 11():. PubMed ID: 35287796
[TBL] [Abstract][Full Text] [Related]
16. Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
Wendt DJ; Dvorak-Ewell M; Bullens S; Lorget F; Bell SM; Peng J; Castillo S; Aoyagi-Scharber M; O'Neill CA; Krejci P; Wilcox WR; Rimoin DL; Bunting S
J Pharmacol Exp Ther; 2015 Apr; 353(1):132-49. PubMed ID: 25650377
[TBL] [Abstract][Full Text] [Related]
17. Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias.
Yasoda A; Nakao K
Endocr J; 2010; 57(8):659-66. PubMed ID: 20567091
[TBL] [Abstract][Full Text] [Related]
18. FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification.
Weizmann S; Tong A; Reich A; Genina O; Yayon A; Monsonego-Ornan E
Matrix Biol; 2005 Dec; 24(8):520-9. PubMed ID: 16253490
[TBL] [Abstract][Full Text] [Related]
19. A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.
Tsuji T; Kunieda T
J Biol Chem; 2005 Apr; 280(14):14288-92. PubMed ID: 15722353
[TBL] [Abstract][Full Text] [Related]
20. An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice.
Kimura T; Bosakova M; Nonaka Y; Hruba E; Yasuda K; Futakawa S; Kubota T; Fafilek B; Gregor T; Abraham SP; Gomolkova R; Belaskova S; Pesl M; Csukasi F; Duran I; Fujiwara M; Kavkova M; Zikmund T; Kaiser J; Buchtova M; Krakow D; Nakamura Y; Ozono K; Krejci P
Sci Transl Med; 2021 May; 13(592):. PubMed ID: 33952673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
